Services
Expertises
Resources
Who we are
Closed

Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition

Supports Canadian-led lobular carcinoma research

Funding available
Varies by project
Deadline
Unspecified
Location
Canada
Who can apply
Canadian research teams
See full eligibility

Overview

Breast Cancer Canada’s 2026 Lobular Carcinoma Research Grant Competition supports Canadian-led breast cancer research focused on precision oncology. It funds targeted diagnostics and targeted treatment projects, including screening, detection, follow-up, surgery, medicine, and radiation.

At a glance

Funding available

Varies by project

Financing goals
  • Develop strategic partnerships
  • Increase social or community impact
  • Conduct research and development activities
  • Raise awareness or mobilize a population
  • Conduct research or evaluation activities

Eligible candidates

Location
  • Canada
Eligible Industries
All industries
Annual revenue
All revenue ranges
Organisation size
All organization sizes
Audience
All groups
Legal structures
All legal structures

Receipt of requests is now closed

Get notified about updates to this grant.

Availability timeline

2026
Periods: 1

Eligibility

Who is eligible?

  • Canadian research teams
  • Canadian-led research projects

Activities funded

  • Precision oncology research in lobular carcinoma
  • Targeted diagnostics, including screening, detection, and follow-up
  • Targeted treatment, including surgery, medicine, and radiation

How to apply

  • Begin the Letter of Intent using the provided link.
  • Submit the Letter of Intent by email to research@breastcancerprogress.ca.
  • Submit the Grant Proposal by the stated deadline.

Documents Needed

  • Letter of Intent
  • Grant Proposal

Selection criteria

  • Strong focus on precision oncology
  • Strong focus on AI-driven innovation
  • Strong focus on patient partnership

Processing and Agreement

  • Letter of Invitation is issued by BCC after the LOI stage.
  • Notice of Decision is issued by BCC on April 17, 2026.

Additional information

  • Applications are accepted by email to research@breastcancerprogress.ca.
  • Applicants may choose a core focus area and a budget category.
  • The program has two grant tiers.
  • Funding starts on June 30, 2026.

Official sources

Add helloDarwin as a preferred source on Google

Frequently Asked Questions about the Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition Program

What is the Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition?

Breast Cancer Canada’s 2026 Lobular Carcinoma Research Grant Competition supports Canadian-led breast cancer research focused on precision oncology. It funds targeted diagnostics and targeted treatment projects, including screening, detection, follow-up, surgery, medicine, and radiation.

Who is eligible for the Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition program?

To be eligible for the Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition program, you must: Canadian-led research projects only Projects must involve active engagement from a breast cancer patient advocate Projects should be grounded in science, data, and lived experience

Who can I contact for more information about the Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition?

You can contact Breast Cancer Society of Canada (BCC).

Where is the Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition available?

The Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition program is available across Canada.

Is the Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition a grant, loan, or tax credit?

Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition is a Grant and Funding

Who are the financial supporters of the Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition?

Breast Cancer Canada 2026 Lobular Carcinoma Research Grant Competition is funded by Breast Cancer Society of Canada (BCC)